SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Galaxy Medicare Ltd (GML)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: GML Medical Equipment/Supplies/Accessories | Small Cap | Galaxy Medicare Share Price

BSE Share Price
Not Listed

Galaxy Medicare Ltd (GML)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: GML Medical Equipment/Supplies/Accessories | Small Cap | Galaxy Medicare Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹29 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹2.3
TTM Sales
₹40 Cr.
Book Value per Share
₹23.9
P/E Ratio
8.54
In line with its 5-year historical median
Industry PE
111.2
Price to Book (P/B)
0.81
Lower than its 5-year historical median
Price to Sales (P/S)
0.73
In line with its 5-year historical median
EV/EBITDA
6.02
In line with its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
19.88%
In line with industry median
Return on Capital Employed (ROCE)
22.61%
Outperforms industry median
Return on Assets (ROA)
10.54%
Operating Profit Margin
12%
Net Profit Margin
8.6%
Gross Profit Margin
12.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.44%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-4.85%
Net Profit Growth (1 Year)
-
-9.16%
Asset Quality
Promoter Holding
72.98%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹21 Cr.
Equity
₹15.2 Cr.
Face Value
₹10
All Time Low / High
- / -

Galaxy Medicare stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Galaxy Medicare Ltd a good quality company?
Galaxy Medicare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Galaxy Medicare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Galaxy Medicare Ltd vs industry peers?
Galaxy Medicare Ltd revenue CAGR is 9.47%, compared to the industry median CAGR of 14.09%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Galaxy Medicare Ltd?
Promoters hold 72.98% of the Galaxy Medicare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Galaxy Medicare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Galaxy Medicare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 4.8%14.3%25.3%22.6%-
Value Creation
Index
-0.70.00.80.6-

Growth Parameters

Sales 29.931.236.239.240
Sales YoY Gr.-4.5%15.8%8.4%-
Adj EPS 0.40.72.82.72.3
YoY Gr.-63.6%290.3%-4.3%-
BVPS (₹) 8.810.113.115.523.9
Adj Net
Profit
0.50.93.33.23
Cash Flow from Ops. -0.63.72.74.5-
Debt/CF from Ops. -17.72.531-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA9.5%8.4%
Adj EPS NANA82.9%-4.3%
BVPSNANA20.9%18.2%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.25171411.4
Op. Profit
Mgn %
8.37.513.812NAN
Net Profit
Mgn %
1.72.79.28.18.5
Debt to
Equity
10.80.50.3-
Working Cap
Days
01641471330
Cash Conv.
Cycle
01031031020

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales29.8831.2136.1539.20
Operating Expenses + 27.4128.9231.2034.50
Manufacturing Costs5.505.816.365.89
Material Costs17.1017.5018.2021.19
Employee Cost 2.602.883.524.26
Other Costs 2.212.733.123.16
Operating Profit 2.462.294.954.71
Operating Profit Margin (%) 8.2%7.3%13.7%12.0%
Other Income + 0.860.820.791.07
Exceptional Items -1.370.960.410
Interest 0.900.950.940.74
Depreciation 0.981.120.480.50
Profit Before Tax 0.0724.734.53
Tax 0.290.431.021.16
Profit After Tax -0.211.573.713.37
PAT Margin (%) -0.7%5.0%10.3%8.6%
Adjusted EPS (₹)-0.21.33.12.8
Dividend Payout Ratio (%)-71.30%9.70%16%26.40%

Valuation of Galaxy Medicare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 16.4017.8221.3824.15
Share Capital 3.043.0411.8611.86
Reserves 13.3614.789.5112.29
Debt +9.267.837.244.53
Long Term Debt3.412.792.010.18
Short Term Debt5.845.045.234.34
Minority Interest0000
Trade Payables3.484.401.611.28
Others Liabilities 1.242.262.241.53
Total Liabilities 30.3932.3132.4731.49

Fixed Assets

Net Fixed Assets +14.5614.2314.4114.13
Gross Block21.2321.6222.2022.43
Accumulated Depreciation6.677.397.808.30
CWIP 0.110.0600
Investments 1.773.033.112.82
Inventories4.904.866.174.92
Trade Receivables7.169.047.336.89
Cash Equivalents 0.490.360.370.48
Others Assets 1.390.731.082.24
Total Assets 30.3932.3132.4731.49

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0.563.652.714.49
PBT 1.441.044.324.53
Adjustment 2.192.021.521.10
Changes in Working Capital -3.830.94-2.04-0.09
Tax Paid -0.36-0.35-1.09-1.06
Cash Flow From Investing Activity + -0.58-1.91-0.650.32
Capex -1.88-0.76-0.21-0.11
Net Investments 1.48-1.22-0.470.27
Others -0.190.060.020.17
Cash Flow From Financing Activity + 1.19-1.80-2.08-4.72
Net Proceeds from Shares 1.01000
Net Proceeds from Borrowing 1.65-0.63-0.78-1.83
Interest Paid -0.88-0.91-0.91-0.69
Dividend Paid -0.07-0.15-0.15-0.59
Others -0.51-0.11-0.25-1.61
Net Cash Flow 0.05-0.07-0.030.09

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-2.0514.0826.9819.88
ROCE (%)4.7814.2725.3222.61
Asset Turnover Ratio0.9811.121.23
PAT to CFO Conversion(x)N/A2.320.731.33
Working Capital Days
Receivable Days87.4094.8082.6066.20
Inventory Days59.9057.1055.7051.60
Payable Days74.3082.2060.3024.90

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Galaxy Medicare Ltd FAQs

The current trading price of Galaxy Medicare on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Galaxy Medicare stood at ₹29.21 Cr

The latest P/E ratio of Galaxy Medicare as of 31-Dec-1969 is 8.54.

The latest P/B ratio of Galaxy Medicare as of 31-Dec-1969 is 0.81.

The 52-week high of Galaxy Medicare is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Galaxy Medicare is ₹40.00 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Galaxy Medicare Ltd is a average quality company.

The key valuation ratios of Galaxy Medicare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Galaxy Medicare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally incorporated on July 23, 1992 as a Limited Company under the name of ‘Galaxy Medicare Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation, issued by Registrar of Companies, Cuttack, Orissa, The Registered Office of the companies is situated at Khurda, Orissa.

The company is into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompasses: manufacturing and branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC; Original Equipment Manufacturers (OEMs) ranging from sourcing of components, designing, manufacturing, quality testing as per the specifications provided by certain brand owners on Principal-to-Principal basis; Institutional sale to various Government Departments through participation in tenders on platforms like GEM Portal; Exporting its manufactured product to international markets; and Trading of medical device and other surgical dressings.

The company is certified under ISO 13485:2016 and Certificate of Conformity from EC International Certifications Standard (CE) for the Manufacturing and selling of Plaster of Paris Bandage and Other surgical Dressings. Over the years, it has established its presence in India and in international markets by offering a wide range of quality consumer products. The company focuses on maintaining strong relationships with the clients and collaborating with them to address their requirements.

Its manufacturing facility has established dedicated teams actively involved in product development cycle which involves research, ideation, concept development, prototyping, testing and launching in the market, Quality Control (QC) and Quality Assurance (QA) Lab activities. These functions have streamlined production and post-production processes and enabled it to support its growth strategy by developing new products and processes that enhance its product range. The focus of its team has been to strive for continuous process improvements that caters to the requirements of global patients emphasizing effectiveness and safety besides achieving manufacturing cost efficiencies. The company offers a range of Plaster of Paris Bandages (POP Bandages), medical tapes and bandages, other surgical dressings, and external preparations for wound care and wound management.

Business area of the company

The company is engaged in the manufacturing, trading, and exporting of Plaster of Paris bandages and other surgical dressings, and is a manufacturer of a wide spectrum of medical devices and surgical products. The company is certified under ISO 13485:2016 and Certificate of Conformity from EC International Certifications Standard (CE) for the Manufacturing and selling of Plaster of Paris Bandage and Other surgical Dressings.

Products of the company

  • Plaster of Paris bandage 
  • Elastic adhesive bandage
  • Hypoallergenic skin barrier microporous surgical tap
  • Cotton crepe bandage
  • Zinc oxide adhesive tape
  • Sterile paraffin gauze dressing
  • Orthopedic wool bandages
  • Cannula fixator
  • Orthopedic casting tape
  • Sterile antiseptic tulle - gras dressing

Key awards, accreditations and recognition

  • 2010: The company has received Special Recognisation Award for Outstanding Entrepreneurship Micro and Small Enterprises (Manufacturing) by Government of India, Ministry of Micro, Small and Medium Enterprises in 2010.
  • 2011: The company has received Third Prize National Award for Outstanding Entrepreneurship Small Enterprises (Manufacturing) by Government of India, Ministry of Micro, Small and Medium Enterprises in 2011.
  • 2012: The company has received the National Productivity Council Award is a prestigious recognition given to its organizations, for their exceptional contributions to productivity enhancement and economic growth. Established in 1958, the National Productivity Council (NPC) of India plays a crucial role in promoting productivity across various sectors of the economy.

History and milestones

  • 1992: The company, ‘Galaxy Medicare Limited’, was established on July 23, 1992, in the Mancheshwar Industrial area of Bhubaneswar, Orissa. Founder of company, Dillip Kumar Das, acquired a closed unit M/s Cure Aids Private Limited and commenced the production of Plaster of Paris Bandage B.P. in the company.
  • 1995: A United Kingdom based Company, selected the company exclusively as their business partner for the manufacturing of their globally renowned Plaster of Paris Bandage B.P. under the brand name ‘GYPSONA’, in its facilities for the regions of India, Sri Lanka, Bangladesh, and Nepal which continued till 1999, when they shifted manufacturing of Plaster of Paris Bandage B.P. to their own facility in Maharashtra.
  • 2002: The company has entered into a partnership with the Indian subsidiary of a Fortune 50 Company of USA with exclusive rights for manufacturing and supply of Plaster of Paris Bandage B.P.
  • 2006: As part of its expansion strategy, the company commenced the manufacturing of Sterile Gauze Dressings, and enhancing its product Portfolio.
  • 2009: Further strengthening its product portfolio, it expanded its manufacturing activities to include Elastic Adhesive Bandage B.P., thereby enhancing its offerings.
  • 2018: The company with continuous hard work and dedicated involvement in quality control (QC) and quality assurance (QA) by the entire team, reached Rs 2777.49 lakh of turnover.
  • 2022: The company has successfully exceeded a turnover of 3073.00 lakh, marking a significant milestone in its financial achievements in the year 2022.
  • 2023: Received One Star Export House Status from Director General of Foreign Trade.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×